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Abstract
Background: The adult subventricular zone (SVZ) contains stem and progenitor cells that generate neuroblasts throughout
life. Although it is well accepted that SVZ neuroblasts are migratory, recent evidence suggests their progenitor cells may
also exhibit motility. Since stem and progenitor cells are proliferative and multipotential, if they were also able to move
would have important implications for SVZ neurogenesis and its potential for repair.
Methodology/Principal Findings: We studied whether SVZ stem and/or progenitor cells are motile in transgenic GFP+ slices
with two photon time lapse microscopy and post hoc immunohistochemistry. We found that stem and progenitor cells;
mGFAP-GFP+ cells, bright nestin-GFP+ cells and Mash1+ cells were stationary in the SVZ and rostral migratory stream (RMS).
In our search for motile progenitor cells, we uncovered a population of motile bIII-tubulin+ neuroblasts that expressed low
levels of epidermal growth factor receptor (EGFr). This was intriguing since EGFr drives proliferation in the SVZ and affects
migration in other systems. Thus we examined the potential role of EGFr in modulating SVZ migration. Interestingly, EGFr
low
neuroblasts moved slower and in more tortuous patterns than EGFr-negative neuroblasts. We next questioned whether
EGFr stimulation affects SVZ cell migration by imaging Gad65-GFP+ neuroblasts in the presence of transforming growth
factor alpha (TGF-a), an EGFr-selective agonist. Indeed, acute exposure to TGF-a decreased the percentage of motile cells by
approximately 40%.
Conclusions/Significance: In summary, the present study directly shows that SVZ stem and progenitor cells are static, that
EGFr is retained on some neuroblasts, and that EGFr stimulation negatively regulates migration. This result suggests an
additional role for EGFr signaling in the SVZ.
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Introduction
The adult subventricular zone (SVZ) is one of two largest
neurogenic areas of the adult brain [1]. The current model of the
adult SVZ delineates three neurogenic cell types: glial fibrillary
acidic protein (GFAP+) stem cells, epidermal growth factor
receptor (EGFr+) transit-amplifying progenitor cells, and double-
cortin (Dcx+) neuroblasts [2,3]. Stem cells divide slowly and
generate transit-amplifying progenitor cells which divide rapidly to
produce neuroblasts [4,5]. Using
3H-thymidine and histological
analyses, Altman showed that neuroblasts migrate in the rostral
migratory stream (RMS), a densely packed corridor of cells
moving from the SVZ to the olfactory bulbs [6]. These and many
other studies of migration were static experiments that determined
the final position of labeled cells or used cell morphology to assess
migration. There are several shortcomings with these approaches.
First, one can never be certain of the trajectory taken by a
migrating cell between its point of origin and final position. In
addition, local motility would not be detected with dye, thymidine
analogue or retroviral labeling and static histological approaches.
Indeed, two-photon time lapse studies revealed that in addition to
long-distance migration, one third of motile SVZ cells move in
local exploratory patterns [7]. Finally, migratory morphology is
not always correlated with motility, motile cells can change shape
dramatically [7]. Thus local motility of stem and progenitor cells,
or even rare long-distance motility may have been missed with
previous approaches. If pluripotential stem cells or rapidly dividing
progenitor cells migrate in the SVZ, they may also migrate to
injuries and be more reparative than SVZ neuroblasts, which are
fate-restricted.
Studies have emerged recently which suggest that transit-
amplifying progenitor cells in the SVZ may be motile. A
population of 29,39-cyclic nucleotide 39-phosphodiesterase-en-
hanced green fluorescent protein/NG2+ cells were identified as
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8122migratory transit-amplifying progenitor cells [8,9]. Other studies
found motile nestin-GFP+ cells that did not express Dcx,
suggesting stem cells or progenitor SVZ cells could be motile [7]
since Dcx is thought to be expressed only in SVZ neuroblasts
[10,11]. In addition, astrocytes and progenitors can be motile in a
variety of developmental systems and after injury [12,13]. Finally,
cells with SVZ progenitor cell characteristics emigrate to the
striatum after injury and growth factor infusion [14].
Epidermal growth factor receptor (EGFr) is thought to be
expressed on stem cells and transit-amplifying progenitor cells in
the SVZ, but to be absent from neuroblasts [2,15]. EGFr
stimulation serves largely to drive proliferation in the SVZ: EGF
infusion into the lateral ventricle increases proliferation [16] and
TGF-a null mice have reduced SVZ cell proliferation [17]. EGF is
also necessary for driving proliferation and self-renewal in the in
vitro neurosphere assay, confirming its central role in SVZ
proliferation [15,18,19]. Interestingly, EGF exposure reverts the
transit-amplifying population to a more stem cell-like state,
suggesting EGFr regulates the balance of SVZ cell subtypes
[15]. Other data show EGFr signaling plays a role in modulating
migration in the forebrain. Interestingly overexpression of EGFr
confers migratory properties on SVZ and other telencephalic cells
[20–22]. Infusing EGF into the lateral ventricle not only
modulates proliferation, but also results in SVZ cells migrating
from their normal route and into the adjacent striatum and septum
[15,16]. Finally, nigrostriatal denervation combined with TGF-a
infusion into the striatum induced emigration of SVZ cells [23,24].
Thus we were interested in the possibility that EGFr modulates
SVZ cell migration.
In this study we first studied transit-amplifying progenitor and
stem cell motility in the adult SVZ. We looked for GFP labeled
SVZ cell subtype motility with two photon microscopy of acute
slices and followed it with post hoc immunohistochemistry to further
examine phenotypes. We show here that stem cells and transit-
amplifying progenitor cells are stationary whereas neuroblasts are
motile. We also show that some neuroblasts retained EGFr
expression and its stimulation is negatively correlated with SVZ
cell motility.
Methods
Animal
Breeder mice were obtained from Vijay Sarthy (Northwestern
U., mGFAP-GFP), Grigori Enikolopov (Cold Spring Harbor Lab,
‘‘CSH-nestin-GFP’’), Anjen Chenn (Northwestern U., ‘‘Nestin-
GFP’’), the NIH Gensat Project (Rockefeller U., Mash1-GFP and
Dcx-GFP) [25], and Ga ´bor Szabo (Institute of Experimental
Medicine, Gad65-GFP). Details of the mGFAP-GFP mouse line
[26], the CSH-Nestin-GFP line [27], the Nestin-GFP line and the
Dcx-GFP line [7], and the Gad65-GFP line [28] are published
elsewhere and summarized in Fig. 1B. The mice used were 1–2
months old. All animals were handled in strict accordance with
good animal practice as defined by the UK Animals (Scientific
Procedures) 1986 Act, UK Home Office and NIH guidelines. All
animal work was approved by the UK Home Office, License
#30/2496, and the University of Oxford Department of
Physiology, Anatomy and Genetics Departmental Ethical Review
Committee.
Slice Preparation and Two Photon Time Lapse Imaging
Details of our two photon (2P) imaging are as previously
described [7]. Briefly, mice were anesthetized with isoflurane
(0.25 ml/L for 1 min), immersed in ice for 5 min, decapitated and
the brain quickly removed, placed in ice-cold artificial cerebro-
spinal fluid (aCSF; 125 mM NaCl, 2.5 mM KCl, 2 mM, CaCl
2,
1 mM MgCl
2, 26 mM NaHCO
3, 1.25 mM H2PO
4, and 25 mM
glucose at pH 7.4). The brain was bisected and trimmed for
mounting. Hemispheres were mounted on a platform, submerged
in ice-cold aCSF and 300 mm sagittal slices cut on a Vibratome
(Campden Instruments Ltd.). Slices were collected sequentially in
a chamber filled with oxygenated aCSF, incubated at 35uC for
40 min, and returned to RT (about 1 hr) before imaging. For cell
imaging, each section was examined shortly under low power
epifluorescence to find the optimal slice and field. A two photon
laser (Mira 900, Coherent) was used to acquire 51 optical sections
separated by 1 mm, every 3 min. Oxygenated aCSF was
constantly perfused during the imaging at 0.5–1.0 ml/min. For
TGF-a experiments, 10 ng/ml TGF-a was dissolved in oxygen-
ated aCSF and either TGF-a, or aCSF as a control, constantly
perfused during imaging at 0.2–0.5 ml/min.
Image Processing and Quantification
Two photon images were acquired as a stack of TIFF images
using Fluoview software (Olympus) and data processed with
Volocity software (Improvision). Briefly, Fluoview files were
imported into Volocity, decompressed and processed with
autocontrast, fine median filter, and auto level functions to obtain
optimal image quality. Each stack of processed data was
compressed and exported into Quicktime (Apple). For quantifying
cell speed and motility, 3D coordinates of cells in each frame were
recorded and calculated using Volocity. If the net distance of
displacement divided by the total migration distance was less than
0.4, between 0.4 and 0.6, or more than 0.6, cells were classified as
exploratory, intermediate, or migratory, respectively. Cell speed
was plotted by dividing total migration distance/time. For
percentage migratory cell analysis in the TGF-a experiments,
the first hour of pre-treatment and the last hour of drug treatment
were quantified. Cells in the first frame of each movie were
numbered and their motility subsequently followed in 2P movies.
Only cells moving more than two cell diameters were considered
motile.
Immunohistochemistry and Confocal Microscopy
For post hoc immunohistochemistry, immediately after the last 2P
frame was taken slices were fixed with 4% paraformaldehyde for
1 hr and transferred to cryoprotectant at 4uC. Slices were washed
with PBS 3 times for 10 min, 50 mM glycine for 15 min, PBS 3
times for 10 min, PBS+ (10% Donkey Serum/0.7% Triton X-100
in PBS) for one hour, and incubated in primary antibodies [sheep
anti-EGFr (1:50, Upstate), mouse anti-Mash1 (1:200, BDscience),
rabbit anti-EGFr (1:200, Santa Cruz, sc-03), rabbit anti-Phospho-
histone 3 (1:500, Millipore), rabbit anti-caspase-3 (1:200, Cell
Signalling Technology), or goat anti-Dcx (1:100, Santa Cruz) in
PBS+]a t4 uC for two days. Then, slices were washed with PBS 3
times 10 min, Cy3 donkey anti-sheep, donkey anti-rabbit or
donkey anti-mouse (all 1:500, Jackson Immunoresearch) or Cy5
donkey anti-goat (1:500, Jackson Immunoresearch) in PBS+ for
1.5 hr, PBS 3 times 10 min, DAPI (40 mg/mL DAPI stock
solution 1:1000 in PBS) for 10 min, PB 3 times 10 min, air dried
and coverslipped with Fluorsave (Calbiochem). Immunostained
slices were examined with confocal microscopy (Zeiss LSM510 or
LSM710). The 2P imaged area was found by comparing the last
frame of 2P imaging with the confocal image, and matching major
blood vessels and static GFP+ cells. Once matched GFP+ cells
were identified, they were numbered and each was examined for
motility patterns and speed in the time lapse movie and for marker
expression with post hoc immunohistochemistry.
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deep anaesthesia with 4% paraformaldehyde. 30 mm sections were
collected on a sliding microtome (Leica) and the same procedure
was used as above except primary antibody incubation was
overnight, 0.1% triton X-100 in PBS, and 1 hr secondary
incubation. Primary antibodies; goat anti-Dcx (1:200, Santa
Cruz), mouse anti-bIII-tubulin (1:500, Covance), sheep anti-EGFr
(1:50, Upstate), or rabbit anti-EGFr (1:200, Santa Cruz, sc-03), or
mouse anti-Mash1 (1:200, BDscience). For triple neuroblast
staining; rabbit anti-Tuj1 (1:2000, Covance), mouse anti-PSA-
NCAM (1:500, Chemicon), goat anti-Dcx (1:100, Santa Cruz).
Secondary antibodies; Alexa488 anti-mouse (1:500, Invitrogen),
Cy3 anti-goat or sheep, Cy5 anti-mouse (1:500, Jackson
Immunoresearch). All immunohistochemistry analysis was done
on N$3 mice.
In Vivo Dye Injection and Quantification
Cell Tracker Orange CMTMR (CTO, Molecular Probes) was
reconstituted in DMSO to a final concentration of 10 mM [29].
Briefly, each animal was deeply anesthetized with 150 mg/kg
ketamine, 10 mg/kg xylazine, i.p., placed in a stereotaxic
apparatus (Stoelting, Wood Dale, IL). A burr-hole was made for
Hamilton syringe insertion and 1 ml of CTO was injected over
1 min into the lateral ventricle (LV) (sterotactic coordinates:
Bregma, A/P: +0.26, L/M: +0.75, D/V:22.5) of 2 month old
Dcx-GFP mice. Animals were placed on a warm pad and
monitored until recovered. 3 days after injection, mice were
perfused as above. Injection into the LV was confirmed in each
mouse with CTO diffusion all the way to the contralateral LV.
Statistics
Statistical differences were determined by Student’s T-test, and
distributions represented by SEM (standard error of mean).
Results
SVZ Stem Cells Were Stationary
We previously characterized and examined motility with two
photon time lapse microscopy in a nestin-GFP mouse that
primarily labels SVZ neuroblasts (Fig. 1B), [7]. We began this
Figure 1. Subventricular zone cell types selectively labeled with GFP. A: Stem cells in the SVZ express GFAP and give rise to EGFr+ and
Mash1+ transit-amplifying progenitors. These, in turn generate migratory neuroblasts that express bIII-tubulin, Dcx, and PSA-NCAM. Note that the
expression and loss of some markers, such as EGFr is gradual. B: Model of a typical SVZ neuroblast chain (red) with cluster of transit-amplifying
progenitors (purple) and GFAP+ astrocytes (blue) surrounding it. For the sake of clarity only a few progenitors (top of chain) and GFAP+ cells (bottom
of chain) are shown. mGFAP-GFP mice only label GFAP+ cells. Nestin-GFP labels a subset of all three cell types and Dcx-GFP labels all and only
neuroblasts. The CSH-nestin-GFP line labels stem cells and transit-amplifying progenitors GFP
bright and neuroblasts GFP
dim. Unexpectedly, the Mash1-
GFP mouse labels not only the transit-amplifying progenitors but also neuroblasts. The Gad65-GFP mouse labels a subset of neuroblasts. Adapted
from [7].
doi:10.1371/journal.pone.0008122.g001
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which GFP
bright cells are neurosphere-forming SVZ stem and
progenitor cells and GFP
dim cells are neuroblasts (Fig. 1B), [27].
Stem cells in the SVZ express GFAP [4,5] (Fig. 1A), and we found
that many GFP
bright cells in the SVZ and the RMS colocalized with
GFAP immunostaining (Fig. 2A,B). We utilized two photon
microscopy to determine if CSH-nestin-GFP
bright cells are motile
(Fig. 2C,D). GFP
bright cells in the SVZ and RMS did not move
during the two hour recording period (N=4 mice, 198 cells in the
SVZ and 586 cells in the RMS) (Fig. 2E,F; Movie S1) while GFP
dim
neuroblasts were actively moving, similar to our previous results
with nestin-GFP mice [7]. We next used a mGFAP-GFP line to
further study potential stem cell motility. Every mGFAP-GFP+ cell
examined in the SVZ and RMS was stationary (N=3 mice, 65 cells
analyzed, 1 hr time lapses) (Fig. 2G–I). These data suggest that
GFAP+ astrocyte-like stem cells are static in the adult SVZ.
Figure 2. Stem and progenitor cells are stationary in the SVZ. A–B: CSH-nestin-GFP showed bright GFP+ cells colocalized with GFAP
immunohistochemistry (blue arrows) in the SVZ (A) and the RMS (B), (coronal sections). Scale bar=50 mm. C: Location of two photon imaging in the
SVZ and RMS of sagittal slices. LV=lateral ventricle, OB=olfactory bulb. D: Schematic of two photon imaging and a 5X image of the RMS in a CSH-
nestin-GFP mouse. E-F: Bright CSH-nestin-GFP+ cells (ex. red arrows) showed no local movement in the RMS in two photon time lapse imaging. Time
stamp is in hr:min in all figures and movies. G–I: All mGFAP-GFP+ cells in the movie were stationary during imaging. Examples of individual cells are
indicated with arrows. Scale bar=30 mm.
doi:10.1371/journal.pone.0008122.g002
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We tested whether transit-amplifying progenitor cells are motile
by using Mash1 and Dcx as positive and negative phenotypic
markers, respectively. Mash1 is a nuclear transcription factor
allowing clear examination of colocalization with GFP in the
CSH-nestin-GFP mouse (Fig. 1A)[14,30]. We confirmed the
previous report that a subset of bright GFP+ cells correspond to
transit-amplifying cells by showing that bright GFP+ cells in the
CSH-nestin-GFP mice expressed Mash1 (Fig. 3A,B). We next
performed two photon imaging (Fig. 3C–D) followed immediately
by post hoc Mash1 and Dcx double immunohistochemistry
(Fig. 3F,G). The last frame of the two photon movie was matched
with the confocal image (compare Fig. 3D and E). After Mash1+/
GFP+ cells were identified and confirmed as being Dcx-negative
(Fig. 3E–G), motility was assessed in the two photon movies. No
Mash1+/Dcx-negative/GFP
bright cells were motile (N=4 mice, 13
cells in the SVZ and 22 cells in the RMS).
To further probe the question of possible transit-amplifying cell
motility, we examined the Mash1-GFP mouse [25]. Double
immunohistochemistry showed not all Mash1-GFP+ cells ex-
pressed endogenous Mash1 in the SVZ and RMS, but the large
majority of Mash1-GFP+ cells were arranged in chains and
expressed Dcx (Fig. 1B, Figure S1A-C). This suggests that, unlike
the endogenous gene, the transgene persists in neuroblasts and is
not a specific marker of transit-amplifying progenitor cells. Time
lapse imaging of Mash1-GFP (N=1 mouse and 1 slice) revealed
migration patterns in the SVZ and RMS (Movie S2) that were
similar to Dcx-GFP+ cell motility [7]. Chains of cells remained
stable, individual cells moved in chains, but were difficult to
discern because of the high cell density. These results precluded
Figure 3. Mash1+ progenitor cells are not motile in the RMS. A–B: Many bright cells from CSH-nestin-GFP slices were colocalized with
Mash1 immunohistochemistry (blue arrows) inthe SVZ (A) and the RMS (B). Scale bar=50 mm. C–D: Motility of CSH-nestin-GFP positive cells was
followed with two photon imaging. Most bright cells were stationary (ex. white arrows). Blue arrow: example of a cell that was followed with
post hoc immunohistochemistry (E–G). Scale bar=50 mm. E–G: the two photon imaged area was found with confocal microscopy. Arrows
indicate cells matched with the last frame of two photon imaging. Mash1+ (F) and Dcx-negative (G) cell shown with blue arrow. Scale
bars=50 mm.
doi:10.1371/journal.pone.0008122.g003
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progenitor cell motility.
In the preceding studies we imaged a small volume of tissue
(6.3610
23 mm
3) for a few hours, and although we sampled a large
number of cells, this was still a small percentage of the whole SVZ
population. We therefore took another approach and labeled a
large population of Mash1+ progenitors in vivo using the dye, Cell
Tracker Orange (CTO). The dye was injected into the lateral
ventricle of Dcx-GFP mice and migration from the SVZ to the
RMS checked three days later (Figure S2A,B). Dcx-GFP mice
faithfully represent endogenous Dcx expression, labeling all, and
only neuroblasts in the SVZ and RMS (Fig. 1B) [7]. Since CTO
diffused through the wall of the LV, (Figure S2A1-2), it labeled
migratory cells irrespective of their location in the SVZ. In
contrast, CTO did not passively diffuse into the RMS (Figure
S2B), ensuring that CTO labeled cells in the RMS migrated there
from the SVZ. Immunostaining revealed that 97.062.7% of
CTO+ cells in the RMS were Dcx-GFP+ and Mash1-negative,
confirming that the large majority of migratory SVZ cells are
Dcx+ neuroblasts (n=3 mice, total 210 cells counted) (Figure
S2C). There were a few CTO+ cells that were Dcx-GFP negative
and Mash1 negative, but there were no CTO+ cells that were
Dcx-GFP-negative and Mash1+ (transit-amplifying progenitor
cells). These results are consistent with the previous result that
Mash1+ transit-amplifying progenitor cells do not migrate from
the SVZ to the RMS.
EGFr Expression on SVZ Neuroblasts
High levels of EGFr expression have been reported on SVZ
transit-amplifying progenitor cells and a few stem cells, but not on
neuroblasts [15]. While examining progenitor cell motility, during
post hoc analysis we serendipitously found a subset of neuroblasts
that exhibited weak levels of EGFr immmunofluorescence. We
examined this in thin sections and found that EGFr expression was
inversely correlated with expression levels of bIII-tubulin (Fig. 4A,
A1-A3). Whereas the majority of EGFr
high cells were at the
periphery of the RMS, the majority of EGFr
low cells were in
longitudinal arrays in the middle of the RMS (Movie S3), which is
consistent with Altman’s original description of the location of
proliferative and migratory cells, respectively [6]. Our data
indicated that a subset of bIII-tubulin+ neuroblasts express EGFr,
so we tested them for expression of two other SVZ neuroblast
markers, Dcx and PSA-NCAM. Both Dcx and PSA-NCAM
showed a similar inverse correlation with EGFr immunohisto-
chemistry (Fig. 4B–E). Moreover, triple immunohistochemistry
(N=3 mice) showed near-perfect overlap of the three neuroblast
markers (Fig. 4F–I). These data prompted the following studies
examining the potential role of EGFr in SVZ neuroblast motility.
EGFr
low Exhibited Slower and More Complex Motility
than EGFr-Negative Neuroblasts
We first tested if motility patterns or speeds were different in
neuroblasts that express EGFr from those that do not. We
examined migration using the nestin-GFP mouse line that we
previously studied [7], in which a relatively small number of SVZ
cells are labeled, allowing individual cell migration analysis
(Fig. 1B; Movie S4). Approximately 63% of GFP+ cells in the
SVZ are neuroblasts in this line [7]; and consistent with the
findings in the present study, we surmised that the only motile
GFP+ cells would be neuroblasts. Again, we imaged cells with two
photon time lapse microscopy and followed it with post hoc
immunohistochemistry (Fig. 5A–E, E1). 12.161.7% of all nestin-
GFP+ cells were EGFr
low and most of these, 83.3616.7%, were
motile (N=3 mice, 93 cells analyzed, average movie length=1 hr
45 min). As described before [7], cell movement was saltatory
(Fig. 5G; Movie S4). EGFr
low cells (ex. red arrow and trace in
Fig. 5) moved slower (N=3 mice, 9 cells analyzed) than EGFr
negative cells (ex. blue arrow and trace in Fig. 5; 19 cells analyzed)
(Table 1, Fig. 5F,G; Movie S4, S5). EGFr
low cells also traveled
significantly shorter total and net distances than EGFr negative
cells (Table 1). In addition to relatively straight rostral movements
we recently reported that approximately one third of SVZ cells
exhibit local exploratory motility [7]. In the present study we
detected both types of movement. The cell in Fig. 5 indicated with
the blue arrow exhibited migratory motility, whereas the cell
indicated with the red arrow exhibited exploratory motility
(Fig. 5A–C, F; Movie S4, S5). The difference in relative
straightness of movement is also apparent in 3-dimensional traces
(Fig. 5F; Movie S5). The migration index is a simple indication of
motility complexity that is independent of speed (MI=net
distance/total distance). Nestin-GFP+/EGFr
low cells exhibited
significantly lower MI (Table 1). These results suggested that
EGFr
low neuroblasts exhibited slower and more tortuous move-
ments than EGFr-negative neuroblasts.
TGF-a Decreased the Percentage of Migratory
Neuroblasts
Since EGFr
low cells exhibited different patterns of motility than
EGFr negative cells, we reasoned that EGFr stimulation may
further affect SVZ neuroblast migration. To directly test this, we
perfused 10 ng/ml transforming growth factor alpha (TGF-a), an
EGFr selective agonist, during two photon time lapse imaging.
In this experiment we used a Gad65-GFP mouse in which the
majority of SVZ neuroblasts are labeled and cells are still
distinguishable from each other (Fig. 1B, 6A–D) [7]. We
confirmed that all periglomerular lineages were represented
(Figure S3). We imaged the RMS (Fig. 6E) with two photon
microscopy for 5 hours: 2 hours (pre-treatment) followed by
perfusion with either 10 ng/ml TGF-a or aCSF (control) for
3 hours (Fig. 6G; Movie S6). We analyzed the first hour of pre-
treatment and the last hour of TGF-a or aCSF treatment. We
previously showed that only a subset of neuroblasts are motile,
suggesting that regulating the percentage of motile cells may be a
robust mechanism for controlling SVZ neurogenesis [7]. After
TGF-a treatment there was a 37.5% loss in the number of motile
cells (Fig. 6I). In the pretreatment group 50.962.0% of Gad65-
GFP cells were motile (total 723 cells traced, n=8 slices, one slice
per mouse) (Fig. 6H). Exposure to TGF-a resulted in only
29.862.1% of cells remaining motile (Fig. 6H) (P=0.008). In
contrast, the percent of motile cells in the fifth hour compared to
the first hour was 98.5%612.9 in controls, showing very little loss
of motility. This result suggests that stimulation of EGFr decreased
the percent of motile cells in the RMS. To examine the direct
effect of TGF-a on EGFr
low neuroblasts, we performed posthoc
EGFr immunohistochemistry on Gad65-GFP slices after TGF-a
treatment (Fig. 6G). It was very difficult to identify EGFr
low
neuroblasts and trace them during the entire 5 hr time-lapse
imaging because most expressed GFP at low levels. None of the
EGFr
low/Gad65-GFP cells exhibited fast and unidirectional
movement, most were non-motile (81.8%), and even motile
EGFr
low/Gad65-GFP cells moved very slowly in the last hour of
imaging (after 2 hr TGF-a treatment) (N=11 cells, N=3 mice).
The cells we followed through the entire imaging (N=3 cells)
moved slowly in pre-treatment but then stopped during most of
the TGF-a treatment. These results suggest a direct effect of EGFr
on EGFr
low neuroblasts.
We next examined patterns and speeds of motility (N=40 cells
in 4 control slices; N=39 cells in 4 TGF-a treated slices). The
EGFr Regulates SVZ Motility
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TGF-a), motility pattern (exploratory, intermediate, and migrato-
ry; 45611.9%, 22.568.5%, and 32.5614.4% for control,
42.5619.7%, 12.569.5%, and 38.7619.4% for TGF-a), total
distance (86.462.8 mm for control and 82.966.7 mm for TGF-a),
and net distance (43.067.2 mm for control and 42.068.0 mm for
TGF-a) were not significantly different between control slices and
the TGF-a treated group. This was not surprising because our
results showed that after TGF-a treatment most of the actively
migrating cells were EGFr negative neuroblasts.
Finally, we checked whether cell death and proliferation were
affected by the TGF-a treatment. This acute 3 hr TGF-a
treatment did not significantly change cell death as measured by
the number of caspase-3+ cells in the RMS (data not shown).
There was a trend towards increased cell proliferation as indicated
by the number of PH3+ cells in the RMS (CTL 204.9624.6 vs.
TGF-a 264.5681.4), but this was not statistically significant.
Discussion
One of the principle aims of this study was to test the hypothesis
that SVZ stem and/or progenitor cells are migratory. Using two
photon time lapse microscopy of slices from multiple GFP+ mouse
lines we did not find any evidence of motile stem or progenitor cells.
Figure 4. A subset of neuroblasts express EGFr. A: bIII-tubulin and EGFr double immunohistochemistry in a coronal section through the RMS.
Many EGFr
high cells were bIII-tubulin-negative (white arrows). A1–A3 shows high magnification of inset in A. Note EGFr
high cell that is bIII-tubulin-
negative (white arrow). Yellow arrow shows a cell that expressed both EGFr and bIII-tubulin. Cells that expressed the highest levels of bIII-tubulin+
(white arrowhead) had EGFr immunofluorescence similar to background levels. Scale bars=10 mm. (Please see Movie S3). B–E: Dcx (B), EGFr (C), and
PSA-NCAM (D) triple immunohistochemistry in the RMS. Simlar colocalization of EGFr with neuroblasts is seen as in A. White arrows point to EGFr
high
cells that are negative for Dcx and PSA-NCAM. Yellow arrows point to cells that express immunodetectable levels of all three markers. White
arrowheads point to neuroblasts that had EGFr immunofluorescence similar to background levels. F–I: Confocal microscopy shows near perfect
overlap between bIII-tubulin, Dcx, and PSA-NCAM in RMS neuroblasts (coronal section).
doi:10.1371/journal.pone.0008122.g004
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progenitor cells, EGFr, was also expressed by a subset of
neuroblasts. Interestingly these EGFr
low neuroblasts exhibited
slower and more complex motility than EGFr-negative neuroblasts.
Moreover, exposure to TGF-a, induced significant decreases in the
percentage of migratory neuroblasts. These results do not support
the recent evidence of progenitor migration and suggest that EGFr
signaling may serve to decrease SVZ neuroblast migration in
addition to modulating progenitor proliferation.
Stem Cells and Transit-Amplifying Progenitor Cells Are
Stationary in the SVZ
When
3H-thymidine, a mitotic label, was injected and the SVZ
examined at short survival times; most forebrain labeled cells were
in the SVZ, indicating a large proliferative population [6]. At
intermediate time points, labeled cells were found in the RMS,
and at long survival times, they had moved to the OB [6]. These
classic labeling studies, as well as histological observations,
prompted the classification of SVZ cells into distinct proliferative
and migratory subpopulations. This model was commensurate
with most migratory cells in the developing telencephalon being
postmitotic; stem and progenitor cells reside in germinal zones and
Figure 5. EGFr expression is correlated with differences in motility. A–C: Two photon time lapse imaging of nestin-GFP cells in the RMS. Blue
and red arrows indicate migratory and exploratory cells, respectively. Scale bar=50 mm. (Please see corresponding Movie S4.). D: Confocal image
corresponding to two photon image shown in C. Scale bar=50 mm. E: After fixation and EGFr immunohistochemistry, confocal microscopy was used
to find individual cells imaged with two photon microscopy (same cell as in A–C shown with red arrow) Scale bar=50 mm. E1: high magnification 3-D
confocal microscopy showing EGFr
low expression (red) on cell exhibiting exploratory motility. Scale bar=20 mm. F: 3D view of motile cell trajectory.
The blue and red trajectories indicate the migratory EGFr negative and exploratory EGFr
low cells shown in A–E. 1 unit=42.9 mm. (Please see
corresponding Movie S5.). G: Cell movement distances between frames (3 min apart) of the EGFr-negative (blue) and EGFr
low (red) nestin-GFP+ cells
shown in A–F. EGFr negative cells were significantly faster than EGFr
low exploratory cells.
doi:10.1371/journal.pone.0008122.g005
Table 1. Motility comparison between EGFr
low cells and EGFr
negative cells.
Total
Distance (mm)
Net Distance
(mm)
Speed
(mm/hr)
Migration
index
EGFr negative
cells
137.0611.4 89.7612.4 83.066.9 0.6060.06
EGFr
low cells 95.3614.8* 41.9614.1* 59.669.2* 0.3760.08*
*P,0.05
doi:10.1371/journal.pone.0008122.t001
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However there are notable exceptions and other clues pointing to
the possibility of stem or progenitor cell migration. Neural crest
stem cells delaminate, migrate extensively, and continue to divide
to generate progeny in the periphery [31]. In the embryonic
cortex, intermediate progenitor cells (transit-amplifying cells)
migrate from the ventricular zone to the subventricular zone
[32,33]. Finally, astrocytes can migrate [34,35] and the SVZ is a
pro-migratory environment. Taken together, this suggested that
GFAP+ astrocyte-like stem cells or transit-amplifying progenitor
cells of the adult SVZ may be capable of motility. This is
important, because if stem or progenitor cells are motile in the
SVZ, they may be able to emigrate and better effectuate repair of
injured tissues than the less plastic neuroblasts.
Intriguingly, three separate lines of evidence suggested SVZ
stem and/or progenitor cells may be motile. A population of
NG2+ cells were identified in the SVZ as transit-amplifying
progenitors that migrated to the OB and the hippocampus
[8,9]. However, NG2-Cre lineage tracing experiments indicate
that NG2+ c e l l si nt h eS V Zd on o tg i v er i s et oO Bn e u r o n s[ 3 6 ] .
Instead NG2+ cells in the SVZ are likely to be oligodendrocyte
progenitor cells which is consistent with them overlapping with
CNPase-GFP [8,36]. Oligodendrocyte progenitors occupy a
distinct caudal subdomain in the SVZ [37], and we did not
test for oligodendrocyte progenitor motility in this study. The
second line of evidence is from two-photon time lapse
microscopy studies showing that a subset of locally motile
nestin-GFP+ cells are Dcx-negative [7]. One interpretation of
these results is that in addition to neuroblasts, transit-amplifying
progenitor cells or GFAP+ cells may be motile [7]. Finally,
dopamine depletion combined with TGF-a infusion induces
migration of SVZ transit-amplifying progenitor cells into the
striatum [14] and intra-cerebroventricular infusion of EGF
enhances progenitor cell proliferation and invasion to the
striatum [38].
We found no evidence of SVZ stem or progenitor cell motility
despite extensively examining the SVZ and RMS, using several
lines of GFP+ mice, and searching for both local and long-
distance motility. Two lines of mice which label GFAP+
astrocytes and stem cells in the SVZ indicated complete lack of
motility. We confirmed that many CSH-Nestin-GFP
bright cells
were GFAP+ or Mash1+, which was consistent with the antigenic
Figure 6. TGF-a decreased the percentage of motile cells. A–D: Gad65-GFP labels a subset of bIII-tubulin+ neuroblasts (arrowheads), but not
EGFr
high progenitor cells (arrows). E: Low magnification view of Gad65-GFP sagittal section showing area analyzed. F: First frame of two photon time
lapse imaging. Each distinguishable cell was labeled (yellow numbers) and analyzed to determine cell motility. Corresponds to first frame of Movie S6
(pretreatment). G: TGF-a schedule and analyzed segments. H: Percentage of motile cells before and after TGF-a treatment. TGF-a caused significant
decreases compared to pretreatment and aCSF. **P,0.01. I: Percentage decrease after TGF-a compared to pre-treatment. *P,0.05.
doi:10.1371/journal.pone.0008122.g006
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GFP mouse dim neuroblasts [27] migrated, serving as an internal
control for the stationary bright GFP+ SVZ stem and progenitor
cells. Importantly we also employed post hoc immunolabeling to
confirm the progenitor phenotypes of non-motile cells. Time
lapse imaging of mGFAP-GFP SVZ cells also did not show any
motility [39]. Astrocytes can be migratory in other contexts,
therefore it is not clear why they should not move in the SVZ,
which provides an environment favorable to migration of
endogenous neuroblasts as well as transplanted cells. Similar to
short migration (2 photon experiments), we did not find any
evidence of long-distance migration of progenitor cells labeled
with CTO.
Our findings are consistent with both Altman’s descriptions of
the SVZ and the RMS [6], as well as with more recent data
showing two largely separate proliferative and migratory popula-
tions in the SVZ [4,40]. It is consistent with data showing that
label-retaining cells (stem cells) reside in the SVZ several days after
3H-thymidine labeling [4]. Similarly, adenoviral labeled radial glia
in the postnatal SVZ gave rise to sessile SVZ astrocytic stem cells
[41]. It is still possible that stem and/or progenitor cell motility
exists, but that it is just very rare and that more sampling would
uncvover it, however we imaged and analyzed 874 cells in our
search. Alternatively, their motility may be inhibited by our
imaging technique - in vivo imaging will ultimately be required to
confirm our results. Finally, we can not rule out the possibility that
stem or progenitor cells are sessile constitutively but brain injury
induces motility.
EGFr
low Neuroblasts Showed Slower Motility
EGFr is one of the most commonly used markers for SVZ
progenitors and is not thought to be expressed by SVZ neuroblasts
[15]. However this study showed low levels of EGFr expression on
some neuroblasts. Similarly, it was recently demonstrated that a
subset of CD24
low FACsorted mouse neuroblasts express unde-
tectable to low levels of EGFr [3], and that rat neuroblasts express
EGFr [42]. We do not know how much of the low EGFr
expression detected on SVZ neuroblasts is inherited from their
EGFr
high precursor cells or transcribed directly, though Cheng
and colleagues found EGFr transcripts in SVZ neuroblasts [43].
We noted an inverse correlation between EGFr and bIII-tubulin
expression, suggesting that EGFr expression is gradually lost as
neuroblasts mature. Alternatively, neuroblast heterogeneity might
explain why only a subset express EGFr. However, the three most
commonly used markers for SVZ neuroblasts, PSA-NCAM, bIII-
tubulin and Dcx were remarkably co-expressed, arguing against
heterogeneity.
Several phenotypic, morphological, and functional studies
suggest that the transition from GFAP+ stem cells to intermediate
transit-amplifying progenitors to migratory neuroblasts is gradual.
The majority of EGFr+ cells in the SVZ are thought to be transit-
amplifying progenitor cells, which reportedly have simple round
morphologies [15]. Yet, we showed that EGFr
high cell morphology
ranges from round, to bipolar, to multipolar. Similarly, the
morphology of motile cells is on a continuum: cells with the classic
bipolar migratory morphology, multipolar cells, and round cells
[7]. SVZ cells can also switch to behavioral repertoires associated
with their progenitors. Despite the evidence for distinct prolifer-
ative and migratory populations described above, there is evidence
that migrating neuroblasts occasionally proliferate [44,45].
Remarkably, magnetic bead sorted PSA-NCAM+ SVZ neuro-
blasts become gliogenic when transplanted, suggesting they lose
their fate commitment and acquire stem cell-like characteristics
[46]. Transit-amplifying progenitors cells can revert to stem cell-
like behaviors when exposed to high levels of EGF [15]. Taken
together, we believe these data are compatible with a model of
gradual and reversible transitions in the lineage between SVZ stem
cells to neuroblasts. Our data that SVZ neuroblasts express EGFr
supports this notion.
Our findings prompted the question of what function, if any,
EGFr has on SVZ neuroblast migration. EGF is a pleiotropic
molecule and EGFr signaling mediates a multiplicity of events in
different contexts. Different levels of EGFr selectively drive
proliferation and astrogliogenesis during early stages of cerebral
cortex development [47]. EGF signaling also regulates adult SVZ
cell division in vivo and is necessary for in vitro generation of
neurospheres [18,19,48]. Interestingly we showed that among
many factors tested, EGF was uniquely increased in the region of
cerebral cortex injury to which SVZ neuroblasts migrate [49].
EGFr also drives SVZ derived oligodendrocyte genesis and repair
after demyelination [50,51]. The combined data suggest that
EGF and EGFr mediate several different normal and repara-
tive functions of the SVZ. EGF and EGFr signaling mediates
migration across several phyla and a wide variety of cells
[52–55]. They are involved in dorsally directed migration of
border cells in invertebrates [56,57]. In the mammalian
telencephalon, asymmetric cell division results in daughter cells
expressing different levels of EGFr [22]. EGFr overexpression
induced motility in non-motile telencephalic cells [9,20].
EGFr
high cells migrate up EGF gradients in the cerebral cortex
and lateral migratory stream but not in the RMS, suggesting that
SVZ/RMS neuroblasts respond differently to EGFr signalling
[21].
In this study we found motile cells that expressed EGFr. We
believe that the nestin-GFP+/EGFr
low cells are neuroblasts since
EGFr
low cells expressed bIII-tubulin, Dcx and PSA-NCAM.
These results show directly that EGFr expression is not
incompatible with migration and expands the behavioral reper-
toire of EGFr+ cells in the SVZ. Recently, local exploratory SVZ
cell motility was seen in nestin-GFP and Gad-GFP mice [7]. Since
the former primarily, and the latter exclusively labels neuroblasts,
it suggested that neuroblasts can exhibit exploratory movement.
Here we found that EGFr
low cells are more exploratory and slower
than motile cells which do not express EGFr. Moreover, EGFr
low
cells traveled shorter net and total distances compared to EGFr
negative cells. In our previous study, Gad-GFP+ cells, which are
thought to be older neuroblasts [58], were significantly faster than
nestin-GFP+ cells [7]. Taken together, EGFr
low cells showed
motility patterns between stationary and migratory cells. One
possible explanation is that EGFr
low cells are recently born
neuroblasts that have not acquired a fully migratory phenotype.
Alternatively, EGFr may be re-expressed when cells slow down or
stop.
Pharmacological EGFr Stimulation Decreased Percentage
of Motile Cells
Previously, we showed that only a subset of SVZ neuroblasts
are migratory at any given time [7], and here we demonstrate
that exposure to the EGFr agonist TGF-a significantly decreased
the percentage of migrating cells. Changing the ratio of
migratory to non-migratory cells would greatly impact newborn
neuron migration rates to the OB. Our results are compatible
with data showing that EGF infusion decreases the number of
newborn neurons that have migrated to the OB [48]. One
potential explanation is that TGF-a acted directly on EGFr
low
neuroblasts. To support this argument, we observed EGFr
low
cells which were motile before TGF-a treatment but stopped
after the treatment. The decreased percent of migrating cells in
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theoretically have to stop moving before they divide. Indeed,
there was a trend towards increased proliferation, even after the
acute 3 hour TGF-a exposure. The short time course also
suggests that TGF-a acted directly on EGFr
low neuroblasts,
although we can not rule out an indirect effect via stimulation
of EGFr
high cells and release of soluble factors from them.
Regardless of whether either scenario is correct, TGF-a
treatment decreased the percentage of motile cells. Several
studies have shown that EGF or TGF-a infusion induce SVZ
neuroblast emigration to the striatum [14–17,23,24]. Although
we did not observe cell emigration to the striatum in slices after
TGF-a, it may be that longer stimulation is needed for this effect.
TGF-a treatment did not change speed, migration distance, and
motility pattern of migrating cells.
Taken together, the data suggest that EGFr stimulation may
first slow down and then inhibit normal migration in the SVZ
and RMS, and in pathological contexts stimulate its emigration
to adjacent nuclei. It also suggests that the high levels of EGFr
on stem and progenitor cells may inhibit this motility. The
dynamics between proliferation and migration are important to
coordinate for regulating neurogenesis. Another member of
the EGFr family, ErbB4, is necessary for normal migration
during brain development [59]. SVZ neuroblasts express
ErbB4, infusion of its ligand neuregulin-1 induces and
maintains motility, and the RMS of ErbB4 conditional nulls is
severely disrupted [60,61]. Instead of promoting migration, our
data suggests stimulation of EGFr, also known as ErbB1,
decreases migration. Thus ErbB1 and ErbB4 signaling may
serve to balance each others’ effects on SVZ proliferation and
migration.
Conclusion
In conclusion, our data confirm early reports of a clear
distinction between proliferative and migratory behaviors and
argue against stem and progenitor migration. They also
indicate that one possible mechanism balancing them is EGFr
signaling.
Supporting Information
Figure S1 Mash1-GFP labels Mash1 progenitor cells and
neuroblasts. A–B: Mash1 immunohistochemistry on Mash1-
GFP mice in the SVZ (A) and the RMS (B). Note that some
immunolabeled Mash1+ cells were Mash1-GFP+ (arrows)
whereas other Mash1+ cells were not Mash1-GFP+ (arrow-
heads). C: Dcx immunohistochemistry in the RMS showed that
most Mash1-GFP+ cells were colocalized with Dcx in the RMS
(arrows).
Found at: doi:10.1371/journal.pone.0008122.s001 (2.58 MB TIF)
Figure S2 Only neuroblasts migrate from the SVZ to the RMS.
A: Schematic of CTO injection, A1: shows injection track into
lateral ventricle, A2: shows diffusion of CTO to the contralateral
lateral ventricle. B: Sagittal section showing CTO injection (red) in
the LV of a Dcx-GFP+ mouse. C: Coronal section, the majority of
CTO+ cells (red) were also Dcx-GFP+ (green, arrows) but were
not Mash1+ (blue, arrowhead). C1. Confocal orthogonal view of
the cell shown with left arrow.
Found at: doi:10.1371/journal.pone.0008122.s002 (8.76 MB TIF)
Figure S3 Gad65-GFP+ cells give rise to all three major
periglomerular cell layer subtypes. Recent studies have shown
that different parts of the SVZ generate different types of
interneurons in the OB [41,62]. We tested if Gad65-GFP+ cells
belong to specific sublineages of OB cells, and found GFP+ cells
that were tyrosine hydroxylase+ (TH)(A), calretinin+ (CalR)(B), or
calbindin+ (CalB)(C) consistent with a previous report [28]. These
results showed that we were not studying selective sublineages of
SVZ neuroblasts. Arrows show examples of co-labeled cells. Scale
bar=50 mm.
Found at: doi:10.1371/journal.pone.0008122.s003 (2.77 MB TIF)
Movie S1 Movie from a CSH-nestin-GFP slice in the RMS,
note that bright GFP+ cells are stationary. Playing movie at high
speeds allows optimal visualization of dim cell movement.
Corresponds to Fig. 2E–F. Frame is 3536353651 (x, y, z) mm.
Found at: doi:10.1371/journal.pone.0008122.s004 (1.57 MB
MOV)
Movie S2 Movie from a Mash1-GFP+ slice at the elbow of the
RMS. Note the visible chain migration because of GFP retention
in migrating neuroblasts. Cells appear to be moving in multiple
different directions in the ventral portion.
Found at: doi:10.1371/journal.pone.0008122.s005 (2.66 MB
MOV)
Movie S3 EGFr immunohistochemistry in the vertical limb of
the RMS, DAPI counterstain. Confocal stack of 32 optical
sections, each separated by 0.37 microns. Note the prepon-
d e r a n c eo fE G F r h i g hc e l l sa tt h ee d g eo ft h eR M S ,m a n yo f
which appear to be clustered. Within the RMS, a range of high
to weak EGFr immunofluorescence is detected in a pattern
suggesting expression by chain migrating neuroblasts. EGFr+
cells had a continuum of morphologies ranging from bipolar to
round.
Found at: doi:10.1371/journal.pone.0008122.s006 (0.49 MB
MOV)
Movie S4 Movie from a Nestin-GFP slice in the RMS. Note
individual cells move with different migratory patterns. Slice was
fixed and immunostained for EGFr, shown in Fig. 5. Frame is
2846295651 (x, y, z) mm.
Found at: doi:10.1371/journal.pone.0008122.s007 (0.72 MB
MOV)
Movie S5 3D tracing of Movie 4. Blue and red trajectories
correspond to migratory and exploratory cells shown with
blue and red arrows in Fig. 5 and Movie 4. Note the difference
between migratory (blue) and exploratory (red) motility
patterns.
Found at: doi:10.1371/journal.pone.0008122.s008 (1.03 MB
MOV)
Movie S6 Two photon time lapse imaging of a Gad65-GFP slice
before (pre-treatment) and during 10 ng/ml TGF-a treatment.
The first hour of pretreatment and the last hour of TGF-a
treatment is shown and were analyzed. One quarter of the field
imaged and analyzed is shown for greater clarity. (Time stamp
reset after pretreatment.)
Found at: doi:10.1371/journal.pone.0008122.s009 (0.57 MB
MOV)
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